Identification of treatments targeting PMLexpressing
breast cancers

dc.contributor.advisor	Carracedo Pérez, Arkaitz	es
dc.contributor.advisor	Martín Martín, Natalia	es
dc.contributor.author	Insausti Urkia, Naroa	es
dc.contributor.other	F. CIENCIA Y TECNOLOGIA	es
dc.contributor.other	ZIENTZIA ETA TEKNOLOGIA F.	eu
dc.date.accessioned	2016-04-28T16:36:11Z
dc.date.available	2016-04-28T16:36:11Z
dc.date.issued	2016-04-28
dc.identifier.uri	http://hdl.handle.net/10810/18047
dc.description.abstract	The main aim of this project is to find a suitable ATO concentration to combine with already approved chemotherapeutic agents to find that synergistic effect in triple negative breast cancer MDA-MB 231 cell line, as a new strategy to treat the disease.	es
dc.language.iso	eng	es
dc.rights	info:eu-repo/semantics/openAccess	es
dc.subject	breast cancer	es
dc.subject	PML	es
dc.subject	arsenic trioxide	es
dc.title	Identification of treatments targeting PMLexpressing breast cancers	es
dc.type	info:eu-repo/semantics/bachelorThesis	es
dc.date.updated	2015-06-23T14:19:49Z	es
dc.language.rfc3066	es	es
dc.rights.holder	© 2015, la autora	es
dc.contributor.degree	Grado en Bioquímica y Biología Molecular	es
dc.contributor.degree	Biokimikako eta Biologia Molekularreko Gradua	es
dc.identifier.gaurregister	60706-655085-09	es
dc.identifier.gaurassign	22701-655085	es